NCT00364351 2018-01-25
Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy
Sanofi
Phase 3 Completed
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi